SAUL J. GROSBERG, M.D.
Since Trousseau1 first described hemochromatosis, much has been written about the disease, as to both its pathology and its possible causation. In the classic monograph by Sheldon,2 myocardial failure is mentioned as an infrequent cause of death in hemochromatosis.
With the advent of the use of insulin, diabetes has ceased to be the prime cause of death in hemochromatosis, and has been replaced by hepatic and cardiac failure.
The reports which have appeared in recent years dealing with the heart in hemochromatosis have all stressed the fact that, once failure has manifested itself, deterioration is rapid, with survival usually
SAUL J. GROSBERG. HEMOCHROMATOSIS AND HEART FAILURE: PRESENTATION OF A CASE WITH SURVIVAL AFTER THREE YEARS' TREATMENT BY REPEATED VENESECTION(HEMOCHROMATOSIS AND HEART FAILURE: PRESENTATION OF A CASE WITH SURVIVAL AFTER THREE YEARS' TREATMENT BY REPEATED VENESECTION*). Ann Intern Med. 1961;54:550–559. doi: 10.7326/0003-4819-54-3-550
Download citation file:
Published: Ann Intern Med. 1961;54(3):550-559.
Cardiology, Heart Failure.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use